Evidence map›Paper›PMID 18595894›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells.

Paola Salvatore, Amelia Casamassimi, Linda Sommese, Carmela Fiorito, Alfredo Ciccodicola, Raffaele Rossiello, Bice Avallone, Vincenzo Grimaldi, Valerio Costa, Monica Rienzo and 12 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Novel Approach for Evaluation ofFrontiers in microbiology · 2016
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Paola SalvatoreDepartment of Cellular and Molecular Biology and Pathology Luigi Califano, School of Biotechnological Sciences, Federico II University of Naples, Naples 80131, Italy.
Amelia Casamassimi
Linda Sommese
Carmela Fiorito
Alfredo Ciccodicola
Raffaele Rossiello
Bice Avallone
Vincenzo Grimaldi
Valerio Costa
Monica Rienzo
Roberta Colicchio
Sharon Williams-Ignarro
Caterina Pagliarulo
Maria Evelina Prudente
Ciro Abbondanza
Florentia Lamberti
Adone Baroni
Elisabetta Buommino
Bartolomeo Farzati
Maria Antonietta Tufano
Louis Joseph Ignarro
Claudio Napoli
University of Naples Federico II · ITInstitute of Genetics and Biophysics · ITUniversity of California, Los Angeles · USIRCCS Policlinico San Donato · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Sannio · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recruitment of circulating endothelial progenitor cells (EPCs) might have a beneficial effect on the clinical course of several diseases. Endothelial damage and detachment of endothelial cells are known to occur in infection, tissue ischemia, and sepsis. These detrimental effects in EPCs are unknown. Here we elucidated whether human EPCs internalize Bartonella henselae constituting a circulating niche of the pathogen. B. henselae invades EPCs as shown by gentamicin protection assays and transmission electron microscopy (TEM). Dil-Ac-LDL/lectin double immunostaining and fluorescence-activated cell sorting (FACS) analysis of EPCs revealed EPC bioactivity after infection with B. henselae. Nitric oxide (NO) and its precursor l-arginine (l-arg) exert a plethora of beneficial effects on vascular function and modulation of immune response. Therefore, we tested also the hypothesis that l-arg (1-30 mM) would affect the infection of B. henselae or tumor necrosis factor (TNF) in EPCs. Our data provide evidence that l-arg counteracts detrimental effects induced by TNF or Bartonella infections via NO (confirmed by DETA-NO and L-NMMA experiments) and by modulation of p38 kinase phosphorylation. Microarray analysis indicated several genes involved in immune response were differentially expressed in Bartonella-infected EPCs, whereas these genes returned in steady state when cells were exposed to sustained doses of l-arg. This mechanism may have broad therapeutic applications in tissue ischemia, angiogenesis, immune response, and sepsis.

Indexed as

ArginineBacterial AdhesionBartonella henselaeCell CountCell SurvivalEndothelial CellsEnzyme ActivationFlow CytometryGene Expression RegulationHumansNitric Oxidep38 Mitogen-Activated Protein KinasesStem CellsTumor Necrosis Factor-alphaArginineNitric Oxidep38 Mitogen-Activated Protein KinasesTumor Necrosis Factor-alpha

Identifiers

PMID18595894
PMCPMC2453733
OpenAlexW2024978560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.